Research Update: ALT Levels in AIH

Research Update: ALT Levels in AIH

By Craig Lammert, M.D., AIHA Executive Director Currently, the most important treatment goal for autoimmune hepatitis (AIH) is normal liver tests (AST and ALT) and IgG levels. These numbers are used by treating doctors as surrogates for AIH-related liver inflammation....
Supporter Spotlight: Lisa Devereaux

Supporter Spotlight: Lisa Devereaux

Autoimmune Hepatitis Association (AIHA) Founding Member Lisa Devereaux has been a longtime supporter of the AIHA, from making monetary donations to volunteering countless hours connecting with other autoimmune hepatitis (AIH) patients. In this Q&A, she shares more...
Recommendation for a Third Vaccine

Recommendation for a Third Vaccine

By the Autoimmune Hepatitis Association Advisers to the Centers for Disease Control and Prevention (CDC) voted unanimously in favor of a third dose of Pfizer (age 12 or up) or Moderna (age 18 or up) COVID-19 vaccines for patients who are moderately to severely...
All in the Family: An extra rare story

All in the Family: An extra rare story

By Erin AndersonAIHA Director of Programs and Advancement If having autoimmune disease were a competition, Lee Gipson (below left) jokes that she would take home the prize over her older sister, Jo McCoy (below right). Gipson has three autoimmune diseases, and McCoy...